LDXHF Financials: Lumos Diagnostics Holdings Ltd AI Analysis

Home

Stock

LDXHF

Financials

LDXHF Financial

Lumos Diagnostics Holdings Ltd

$0.15

At close: Mar 24, 16:00:00 GMT-4

$0.15

Post-market: Mar 24, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.157

Open

$0.19

Day's Range

$0.157 - $0.19

52 week range

$0.01 - $0.2105

Volume

10.0K

Avg.Volume

49.4K

Dividend yield

EPS (TTM)

-0.01

Market Cap

$125.2M

What is LUMOS DIAGNOSTICS HLDGS LTD?

Lumos Diagnostics Holdings Ltd. engages in the development and manufacture of point-of-care diagnostics solutions to help healthcare professionals more accurately diagnose and manage medical conditions. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2021-07-05. The firm offers customized assay development and manufacturing services for POC tests and digital reader platforms. The company also directly develops, manufactures, and commercializes Lumos-branded POC tests that target infectious and inflammatory diseases. Its Products offering is based on developing and commercializing its own suite of POC diagnostic products which are primarily focused on the diagnosis and management of infectious diseases. These include FebriDx, a POC test for detecting and differentiating viral and bacterial respiratory infections, and ViraDx, a rapid point-of-care diagnostic product that simultaneously tests for acute respiratory infections caused by the COVID-19, influenza A, and influenza B viruses. The company manages the full development program for POC assays.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

LDXHF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	12	12	11	10	11	18
Revenue Growth (YoY)	-14%	9%	10%	-9%	-39%	260%
Cost of Revenue	4	4	4	4	7	10
Gross Profit	7	7	7	5	4	8
Selling, General & Admin	15	12	11	11	26	18
Research & Development	0	0	0	0	1	1
Operating Expenses	15	14	13	15	28	19
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-9	-7	-8	-8	-45	-15
Income Tax Expense	0	0	0	0	0	0
Net Income	-9	-7	-8	-8	-45	-15
Net Income Growth	125%	-13%	0%	-82%	200%	67%
Shares Outstanding (Diluted)	772.43	680.18	493.65	250.28	223.7	150.15
Shares Change (YoY)	26%	38%	97%	12%	49%	-6%
EPS (Diluted)	-0.01	-0.01	-0.01	-0.03	-0.2	-0.1
EPS Growth	39%	-39%	-51%	-82%	104%	77%
Free Cash Flow	-2	-9	0	-9	-22	-19
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	58.33%	58.33%	63.63%	50%	36.36%	44.44%
Operating Margin	-66.66%	-50%	-54.54%	-90%	-209.09%	-55.55%
Profit Margin	-75%	-58.33%	-72.72%	-80%	-409.09%	-83.33%
Free Cash Flow Margin	-16.66%	-75%	0%	-90%	-200%	-105.55%
EBITDA	-6	-4	-4	-6	--	--
EBITDA Margin	-50%	-33.33%	-36.36%	-60%	--	--
D&A For EBITDA	2	2	2	3	--	--
EBIT	-8	-6	-6	-9	-23	-10
EBIT Margin	-66.66%	-50%	-54.54%	-90%	-209.09%	-55.55%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Follow-Up Questions

What are Lumos Diagnostics Holdings Ltd's key financial statements?



According to the latest financial statement (Form-10K), Lumos Diagnostics Holdings Ltd has a total asset of $20, Net loss of $-7

What are the key financial ratios for LDXHF?



Lumos Diagnostics Holdings Ltd's Current ratio is 1.42, has a Net margin is -58.33, sales per share of $0.01.

How is Lumos Diagnostics Holdings Ltd's revenue broken down by segment or geography?



Lumos Diagnostics Holdings Ltd largest revenue segment is Services, at a revenue of 15,084,972 in the most earnings release.For geography, United States is the primary market for Lumos Diagnostics Holdings Ltd, at a revenue of 16,986,426.

Is Lumos Diagnostics Holdings Ltd profitable?



no, according to the latest financial statements, Lumos Diagnostics Holdings Ltd has a net loss of $-7

Does Lumos Diagnostics Holdings Ltd have any liabilities?



yes, Lumos Diagnostics Holdings Ltd has liability of 14

How many outstanding shares for Lumos Diagnostics Holdings Ltd?



Lumos Diagnostics Holdings Ltd has a total outstanding shares of 748.52

Lumos Diagnostics Holdings Ltd (LDXHF) Financial

LDXHF Stock Price Chart